Nesina Dosage
Generic name: ALOGLIPTIN BENZOATE 6.25mg
Dosage form: tablet, film coated
Drug class: Dipeptidyl peptidase 4 inhibitors
Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.
Recommended Dosage
- The recommended dosage of NESINA is 25 mg taken orally once daily. Do not split tablets.
- NESINA may be taken with or without food.
- Instruct patients if a dose is missed, not to double their next dose.
Patients with Renal Impairment
- Assess renal function prior to initiation of NESINA and periodically thereafter.
- No dose adjustment of NESINA is necessary for patients with mild renal impairment (creatinine clearance [CrCl] ≥60 mL/min).
- The dose of NESINA is 12.5 mg once daily for patients with moderate renal impairment (CrCl ≥30 to <60 mL/min).
- The dose of NESINA is 6.25 mg once daily for patients with severe renal impairment (CrCl ≥15 to <30 mL/min) or with end-stage renal disease (ESRD) (CrCl <15 mL/min or requiring hemodialysis). NESINA may be administered without regard to the timing of dialysis. NESINA has not been studied in patients undergoing peritoneal dialysis.
More about Nesina (alogliptin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.